Search

James B. Mullins

Examiner (ID: 18343)

Most Active Art Unit
2502
Art Unit(s)
2711, 2603, 2607, 2817, 2506, 2602, 2502, 2515, 2504
Total Applications
2038
Issued Applications
1913
Pending Applications
38
Abandoned Applications
87

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 13926083 [patent_doc_number] => 20190046557 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-02-14 [patent_title] => CANCER TREATMENT USING BETA-(1-3)-(1-4)-GLUCAN [patent_app_type] => utility [patent_app_number] => 16/059511 [patent_app_country] => US [patent_app_date] => 2018-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11189 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16059511 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/059511
Cancer treatment using beta-(1-3)-(1-4)-glucan Aug 8, 2018 Issued
Menu